AmerisourceBergen (NYSE:ABC – Get Rating) had its price objective decreased by equities researchers at Morgan Stanley from $178.00 to $175.00 in a note issued to investors on Friday, Stock Target Advisor reports. The brokerage presently has an “equal weight” rating on the stock. Morgan Stanley’s price objective indicates a potential upside of 12.32% from the stock’s current price.
Several other equities research analysts also recently issued reports on ABC. Deutsche Bank Aktiengesellschaft lowered their price target on AmerisourceBergen from $168.00 to $167.00 in a research report on Wednesday. Argus increased their price objective on AmerisourceBergen from $140.00 to $160.00 in a research note on Monday, March 14th. Robert W. Baird boosted their target price on shares of AmerisourceBergen from $179.00 to $187.00 in a research note on Thursday, May 5th. StockNews.com raised shares of AmerisourceBergen from a “buy” rating to a “strong-buy” rating in a research note on Friday, May 6th. Finally, Barclays raised AmerisourceBergen from an “equal weight” rating to an “overweight” rating and boosted their target price for the stock from $175.00 to $182.00 in a report on Thursday. Four analysts have rated the stock with a hold rating, three have assigned a buy rating and one has issued a strong buy rating to the stock. Based on data from MarketBeat.com, the company has a consensus rating of “Buy” and an average target price of $168.29.
ABC opened at $155.80 on Friday. AmerisourceBergen has a 1-year low of $111.34 and a 1-year high of $167.19. The company has a market capitalization of $32.63 billion, a price-to-earnings ratio of 19.00, a price-to-earnings-growth ratio of 1.63 and a beta of 0.45. The business has a 50 day moving average price of $156.56 and a two-hundred day moving average price of $141.13. The company has a debt-to-equity ratio of 5.13, a current ratio of 0.92 and a quick ratio of 0.56.
In related news, EVP Gina Clark sold 43,704 shares of the business’s stock in a transaction that occurred on Monday, March 28th. The stock was sold at an average price of $153.71, for a total transaction of $6,717,741.84. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, major shareholder Walgreens Boots Alliance, Inc. sold 6,000,000 shares of the business’s stock in a transaction that occurred on Wednesday, May 11th. The stock was sold at an average price of $150.00, for a total value of $900,000,000.00. Following the sale, the insider now owns 52,854,867 shares of the company’s stock, valued at approximately $7,928,230,050. The disclosure for this sale can be found here. Insiders sold a total of 6,078,379 shares of company stock worth $912,048,947 over the last 90 days. 28.40% of the stock is owned by corporate insiders.
Hedge funds and other institutional investors have recently made changes to their positions in the business. Herold Advisors Inc. acquired a new stake in shares of AmerisourceBergen in the 1st quarter valued at approximately $31,000. KB Financial Partners LLC bought a new stake in AmerisourceBergen in the fourth quarter valued at approximately $31,000. Massmutual Trust Co. FSB ADV raised its holdings in AmerisourceBergen by 133.3% during the 1st quarter. Massmutual Trust Co. FSB ADV now owns 210 shares of the company’s stock worth $32,000 after purchasing an additional 120 shares during the last quarter. Gemmer Asset Management LLC acquired a new position in shares of AmerisourceBergen in the 4th quarter worth approximately $33,000. Finally, Cassady Schiller Wealth Management LLC acquired a new stake in shares of AmerisourceBergen during the fourth quarter worth $33,000. 64.17% of the stock is owned by hedge funds and other institutional investors.
About AmerisourceBergen (Get Rating)
AmerisourceBergen Corporation sources and distributes pharmaceutical products in the United States and internationally. Its Pharmaceutical Distribution segment distributes brand-name and generic pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to various healthcare providers, including acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and alternate site pharmacies, and other customers.
- Get a free copy of the StockNews.com research report on AmerisourceBergen (ABC)
- Affirm Stock Has Affirmed a Bottom
- Airbnb: Bold Competitive Threats & A New World of Travel
- Is RBC Bearings Rolling Into A Reversal?
- Should Dollar General or Dollar Tree Give Investors a Case of FOMO?
- Genesco Pops On Earnings But Don’t Expect A Rally
Receive News & Ratings for AmerisourceBergen Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AmerisourceBergen and related companies with MarketBeat.com's FREE daily email newsletter.